Benefit of antenatal glucocorticoids according to the cause of very premature birth
- 1Division of Neonatology, Antoine-Béclère University Hospital, Assistance Publique/Hôpitaux de Paris, Clamart, France
- 2Division of Neonatology, Poissy-Saint Germain Hospital, Poissy, France
- 3Epidemiological Research Unit on Perinatal and Women’s Health, INSERM U149, Villejuif, France
- Correspondence to:
Dr Lacaze-Masmonteil
Antoine-Béclère University Hospital, Assistance Publique/Hôpitaux de Paris, 157 rue de la porte de Trivaux, 92141 Clamart, Cedex, France; tlacazeclub-internet.fr
- Accepted 8 June 2004
Abstract
In this observational study performed in a large cohort of very preterm singletons, respiratory outcome was found to be strongly dependent on the cause of premature delivery. Although less apparent in infants born to mothers with chorioamnionitis, exposure to antenatal glucocorticoids remained significantly associated with a decrease in the incidence of respiratory distress syndrome after adjustment for the main cause of premature birth.
- AG, antenatal glucocorticoid
- BPD, bronchopulmonary dysplasia
- IUGR, intrauterine growth restriction
- RDS, respiratory distress syndrome
